Overexpression of cyclin D1 in meningioma is associated with malignancy grade and causes abnormalities in apoptosis, invasion and cell cycle progression

Medical Oncology

Volumn 32, Issue 1, 2015, Pages 1-8

  Cheng, Gang ^a   Zhang, Leiming ^a   Lv, Wenying ^a   Dong, Chao ^a   Wang, Yaming ^a   Zhang, Jianning ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Apoptosis; Cyclin D1; Invasion; Meningioma; Recurrence

Indexed keywords

CYCLIN D1; GELATINASE B; PROTEIN BCL 2; SMALL INTERFERING RNA; SURVIVIN; CCND1 PROTEIN, HUMAN; TUMOR MARKER;

APOPTOSIS; ARTICLE; CANCER GRADING; CELL CYCLE PROGRESSION; CELL DEATH; CELL PROLIFERATION; CH157 CELL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IOMM LEE CELL; MAJOR CLINICAL STUDY; MENINGIOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR GROWTH; TUMOR INVASION; TUMOR RECURRENCE; WESTERN BLOTTING; BIOSYNTHESIS; CELL CYCLE; GENETIC TRANSFECTION; PATHOLOGY; PHYSIOLOGY; UPREGULATION;

APOPTOSIS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CELL CYCLE; CYCLIN D1; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MENINGEAL NEOPLASMS; MENINGIOMA; NEOPLASM GRADING; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; UP-REGULATION;

EID: 84920112917     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0439-0     Document Type: Article

References (28)

1. Bondy M, Ligon BL. Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol. 1996;29(3):197–205.
2. Shetty R, Sharma RM, Pandey P. Diaphragma sella meningioma presenting with posterior cerebral artery infarct: case report and review of literature. Neurol India. 2014;62(1):77–8.
3. Maier H, et al. Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg. 1992;77(4):616–23.
4. Tashiro E, Tsuchiya A, Imoto M. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci. 2007;98(5):629–35.
5. Liao D, et al. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case–control study and meta-analysis. PLoS ONE. 2014;9(11):e113299.
6. Li X, et al. Genetic association between cyclin D1 polymorphism and breast cancer susceptibility. Tumour Biol. 2014. doi:10.1007/s13277-014-2489-5.
7. Wang J, et al. Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells. J Neurooncol. 2012;106(3):473–84.
8. Baldin V, et al. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 1993;7(5):812–21.
9. Yu Q, Geng Y, Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature. 2001;411(6841):1017–21.
10. Gao P, et al. Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance. World J Gastroenterol. 2004;10(20):2936–9.
11. Ravikumar G, Ananthamurthy A. Cyclin D1 expression in ductal carcinoma of the breast and its correlation with other prognostic parameters. J Cancer Res Ther. 2014;10(3):671–5.
12. Toyoda H, et al. Cyclin D1 expression is useful as a prognostic indicator for advanced esophageal carcinomas, but not for superficial tumors. Dig Dis Sci. 2000;45(5):864–9.
13. Bahnassy AA, et al. Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients. BMC Gastroenterol. 2004;4:22.
14. Cakina S, et al. Relationship between cyclin D1 (A870G) gene polymorphism and lung cancer. Indian J Biochem Biophys. 2013;50(3):233–6.
15. Zhou P, et al. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene. 1995;11(3):571–80.
16. Jiang W, et al. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene. 1993;8(12):3447–57.
17. Wang Q, et al. RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis. Carcinogenesis. 2013;34(4):916–26.
18. Wang Q, et al. Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells. J Neurooncol. 2013;112(1):73–82.
19. Barresi V, et al. MMP-9 expression in meningiomas: a prognostic marker for recurrence risk? J Neurooncol. 2011;102(2):189–96.
20. Tummalapalli P, et al. RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis. Int J Oncol. 2007;31(5):1039–50.
21. Okada M, et al. Matrix metalloproteinase-2 and matrix metalloproteinase-9 expressions correlate with the recurrence of intracranial meningiomas. J Neurooncol. 2004;66(1–2):29–37.
22. Nordqvist AC, Smurawa H, Mathiesen T. Expression of matrix metalloproteinases 2 and 9 in meningiomas associated with different degrees of brain invasiveness and edema. J Neurosurg. 2001;95(5):839–44.
23. Uren AG, et al. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol. 2000;10(21):1319–28.
24. Grossman D, et al. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci USA. 2001;98(2):635–40.
25. Olie RA, et al. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res. 2000;60(11):2805–9.
26. Ai Z, et al. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Cancer. 2006;107(4):746–56.
27. Koehler BC, et al. Beyond cell death—antiapoptotic Bcl-2 proteins regulate migration and invasion of colorectal cancer cells in vitro. PLoS ONE. 2013;8(10):e76446.
28. Hassankhani R, et al. Prodigiosin isolated from cell wall of Serratia marcescens alters expression of apoptosis-related genes and increases apoptosis in colorectal cancer cells. Med Oncol. 2015;32(1):366.